| Literature DB >> 30784659 |
George W Burke1, Alessia Fornoni2.
Abstract
Focal segmental glomerulosclerosis is a glomerular disorder with a high rate of recurrence. Although kidney biopsies remain the gold standard to diagnose recurrent focal segmental glomerulosclerosis, non-invasive prognostic assays could facilitate preventive treatments and offer insight into disease pathogenicity and heterogeneity. Srivastava et al. describe a simple, cell-based assay to predict recurrence of focal segmental glomerulosclerosis. Although the study needs to be optimized and validated, its novelty is that it does not depend on the specificity of a given permeability factor.Entities:
Mesh:
Year: 2019 PMID: 30784659 DOI: 10.1016/j.kint.2018.11.032
Source DB: PubMed Journal: Kidney Int ISSN: 0085-2538 Impact factor: 10.612